Mast Energy Developments PLC — AGM Information 2025

Jul 8, 2025

National Storage Mechanism | Additional information

RNS Number : 2074Q

Mast Energy Developments PLC

08 July 2025

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

8 July 2025

Mast Energy Developments PLC

Results of General Meeting 

Mast Energy Developments PLC ("MED" or "the Company") the UK-based multi-asset owner, developer, and operator in the rapidly growing Flexible Generation Power market , announces the results of voting at its General Meeting ("GM") held today.  

Proxies were received by shareholders holding 31.14% of the shares in MED (426,354,067 shares issued and outstanding).  All resolutions were passed.

Pieter Krügel, MED CEO, commented : "We are delighted that the Company's shareholders support our plan to complete the Equity Fundraise, by approving the capital reorganisation which is a key condition to closing. With this condition now satisfied, the only remaining key condition is the approval and publication of the Supplemental Prospectus, which we expect to happen shortly. Following the successful satisfaction of the conditions to the Equity Fundraise, we expect the transaction to complete shortly thereafter. We are looking forward to updating the market with further positive news in this regard over the coming days."

The proxy voting details at the GM are shown on the table below:

Resolution #	*Summary Resolution	Votes cast For & With Discretion		Votes cast Against			Votes Withheld
		Number	%	Number	%	Number
---	---	---	---	---	---	---	---
ORDINARY RESOLUTIONS
1.	That the Director Share Scheme be approved.	128,745,261	97.21	3,695,873	2.79	343,829
2.	To approve sub-division & re-classification of Company share capital	115,680,866	87.17	17,027,309	12.83	76,788
3.	To approve consolidation of Company share capital	116,530,519	87.82	16,169,013	12.18	85,431
4.	THAT the Directors be, and they are hereby generally and unconditionally authorised to exercise all powers of the Company to allot relevant securities	128,336,645	97.25	3,629,943	2.75	818,375
SPECIAL RESOLUTIONS
5.	The New Articles of Association be adopted	115,844,696	88.10	15,650,326	11.90	1,289,941
6.	THAT the Directors be, and they are hereby empowered pursuant to Section 570 of the Act to allot equity securities approved under Resolution 4, as if Section 561(1) of the Act did not exist	127,156,127	96.70	4,342,795	3.30	1,206,041
* The full text of the Resolutions can be found on the Notice of GM on the MED website at: https://www.med.energy/companydocuments

Admission of Consolidated Share Capital

Following the passing of all resolutions at today's GM and pending receipt of stamped approval of the Prospectus by the FCA expected shortly, the Company will immediately make application to the LSE and FCA for the newly consolidated share capital to be re-admitted to the LSE which is expected to occur on or around 14 July 2025. Application will be made for the admission of 10,658,851 n ew Ordinary Shares of par value £0.001 each (the "Admission"). The updated expected timetable of events from here is shown on the table below.

EXPECTED TIMETABLE OF EVENTS

Event	Expected time and date
Announcement of results of the General Meeting	8 July 2025 (This Announcement)
Record Date for Capital Reorganisation	6.00 p.m. on 11 July 2025
Latest Time and date for dealing in Existing Ordinary Shares	6.00 p.m.  on 11 July 2025
Expected date of Publication of Supplemental Prospectus	9 July 2025
Expected date of Admission of New Ordinary Shares to LSE	14 July 2025
Expected date CREST accounts are to be credited with New Ordinary Shares in uncertificated form	14 July 2025
Dispatch of definitive certificate for New Ordinary Shares (in certificated form)	no later than 31 July 2025

The Company will update shareholders by RNS announcement, should there be any changes to the above timetable.

The ISIN for the New Ordinary Shares will be GB00BNG90H86 (SEDOL: BNG90H8) and the

LSE TICKER will remain as: MAST.

Share Information

Number of Existing Ordinary Shares in issue at the Last Pra c ticable Date.	426,354,067
Total expected number of New Ordinary Shares in issue fo l lowing the Capital Reorganisation.	10,658,851

Total Voting Rights

Application will be made to the London Stock Exchange for admission of the 10,658,851 New Ordinary Shares to trading on LSE ("Admission"). It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence at 8.00 a.m. on or around 1 4 July 2025.

Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 10,658,851 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to  the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Capitalised terms used in this announcement have the same meaning as those given to them in the 16 June 2025 RNS announcement (Notice of General Meeting) unless otherwise defined.

Stay up to date with MED's latest news and updates by joining our emailing list and social media channels, as follows:

MED emailing list - https://www.med.energy/contact

MED LinkedIn page - https://uk.linkedin.com/company/mast-energy-developments-plc

MED X (formerly Twitter) handle - @mastplc

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Pieter Krügel	info@med.energy	Mast Energy Developments PLC	CEO
Jon Belliss	+44 (0)20 7399 9425	Novum Securities	Corporate Broker
Guy Wheatley, CFA	+44 (0)74 9398 9014	Fortified Securities	Corporate Broker

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMFLFLLDRITIIE